46.45.Z - Wholesale trade of perfumes and cosmetics
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
70.22.Z - Head office activities and management consultancy
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss) | 63,5 | 52,3 | 38,2 | -27 |
EBITDA | 48,4 | 39,4 | -18,6 | |
Short time liabilities | 23,8 | 24,7 | 24,1 | -2,1 |
Equity capital | 266,3 | 252,2 | 238,3 | -5,5 |
Operating profit (EBIT) | 63,6 | 48,4 | 39,4 | -18,6 |
Assets | 290,1 | 276,9 | 262,5 | -5,2 |
Net profit (loss) | 59,9 | 47,9 | 34,1 | -28,9 |
Cash | 98,3 | 116,7 | 18,6 | |
Liabilities and provisions for liabilities | 23,8 | 24,7 | 24,1 | -2,1 |
Net income from sale | 639,4 | 668,7 | 619 | -7,4 |
Working assets | 290,1 | 276,9 | 262,5 | -5,2 |
Depreciation | 0 | 0 | 0 | |
% | % | % | p.p. | |
Profitability of capital | 22,5 | 19 | 14,3 | -4,7 |
Equity capital to total assets | 91,8 | 91,1 | 90,8 | -0,3 |
Gross profit margin | 9,9 | 7,8 | 6,2 | -1,6 |
EBITDA Margin | 7,2 | 6,4 | -0,8 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 14 | 13 | 14 | 1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane